These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1495526)
1. The prevention of heart failure--a new agenda. Cohn JN N Engl J Med; 1992 Sep; 327(10):725-7. PubMed ID: 1495526 [No Abstract] [Full Text] [Related]
2. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C; Cosentino E; De Sanctis D Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921 [TBL] [Abstract][Full Text] [Related]
3. ACE inhibitors after myocardial infarction. Jackson G Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152 [No Abstract] [Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
5. Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. Kenchaiah S; Davis BR; Braunwald E; Rouleau JL; Dagenais GR; Sussex B; Steingart RM; Brown EJ; Lamas GA; Gordon D; Bernstein V; Pfeffer MA; Am Heart J; 2004 Aug; 148(2):356-64. PubMed ID: 15309009 [TBL] [Abstract][Full Text] [Related]
6. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors. Sigurdsson A Blood Press Suppl; 1995; 1():1-45. PubMed ID: 7599749 [TBL] [Abstract][Full Text] [Related]
8. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians. Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572 [TBL] [Abstract][Full Text] [Related]
9. Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction. Maia LN; Nicolau JC; Vítola JV; Santos M; Brandi JM; Joaquim MR; Baggi JM; Cordeiro JA; de Godoy MF Am Heart J; 2003 Jun; 145(6):E21. PubMed ID: 12796769 [TBL] [Abstract][Full Text] [Related]
11. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. Ambrosioni E; Borghi C; Magnani B N Engl J Med; 1995 Jan; 332(2):80-5. PubMed ID: 7990904 [TBL] [Abstract][Full Text] [Related]
12. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials. Saha SA; Molnar J; Arora RR J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946 [TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin-converting enzyme inhibitors in congestive heart failure. Galvao M Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159 [TBL] [Abstract][Full Text] [Related]
14. Valsartan, captopril, or both in myocardial infarction. McAnulty JH N Engl J Med; 2004 Feb; 350(9):943-5; author reply 943-5. PubMed ID: 14985495 [No Abstract] [Full Text] [Related]
15. [ACE-inhibitors and heart failure. Results of studies of left ventricular dysfunction]. Bornkessel B; Heinzl S Med Monatsschr Pharm; 1992 Mar; 15(3):76-80. PubMed ID: 1569912 [No Abstract] [Full Text] [Related]
16. The use of angiotensin-converting enzyme inhibitors after acute myocardial infarction. Mehra IV; Wilson MD Pharmacotherapy; 1993; 13(5):440-6. PubMed ID: 8247909 [TBL] [Abstract][Full Text] [Related]
17. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors]. Guéret P; Cohen-Solal A; Bensaid J Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1709-16. PubMed ID: 1304144 [TBL] [Abstract][Full Text] [Related]
19. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). McMurray J; Solomon S; Pieper K; Reed S; Rouleau J; Velazquez E; White H; Howlett J; Swedberg K; Maggioni A; Køber L; Van de Werf F; Califf R; Pfeffer M J Am Coll Cardiol; 2006 Feb; 47(4):726-33. PubMed ID: 16487836 [TBL] [Abstract][Full Text] [Related]
20. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]